tradingkey.logo

National Research Corp

NRC
19.010USD
+0.130+0.69%
Close 12/23, 16:00ETQuotes delayed by 15 min
430.72MMarket Cap
26.72P/E TTM

National Research Corp

19.010
+0.130+0.69%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of National Research Corp

Currency: USD Updated: 2025-12-22

Key Insights

National Research Corp's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 100/156 in the Professional & Commercial Services industry.Institutional ownership is very high.In the medium term, the stock price is expected to trend up.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

National Research Corp's Score

Industry at a Glance

Industry Ranking
100 / 156
Overall Ranking
338 / 4578
Industry
Professional & Commercial Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Analyst Rating

Based on 0 analysts
--
Current Rating
0.000
Target Price
0.00%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

National Research Corp Highlights

StrengthsRisks
National Research Corporation, doing business as NRC Health, is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare organizations in the United States. Its digital solutions consist of four solution categories: Patient Experience, Consumer Experience, Employee Experience, and Market Experience, which can be implemented both collectively as an enterprise solution or individually to meet specific needs within the organization. Its Marketing solutions are subscription-based services that allow for improved tracking of awareness, perception, and consistency of healthcare brands; real-time assessment of competitive differentiators, and enhanced segmentation tools. Its Reputation solutions allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs better consumer decision-making.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 45.67%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 45.67%.
Fairly Valued
The company’s latest PE is 26.42, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 11.69M shares, decreasing 12.82% quarter-over-quarter.
Held by Barrow Hanley
Star Investor Barrow Hanley holds 42.00 shares of this stock.

Financial Health

Currency: USD Updated: 2025-12-22

The current financial score of National Research Corp is 7.67, ranking 61/156 in the Professional & Commercial Services industry. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 34.61M, representing a year-over-year decrease of 3.38%, while its net profit experienced a year-over-year decrease of 27.53%.

Score

Industry at a Glance

Previous score
7.67
Change
0

Financials

4.70

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

9.25

Operational Efficiency

8.95

Growth Potential

6.73

Shareholder Returns

8.70

National Research Corp's Company Valuation

Currency: USD Updated: 2025-12-22

The current valuation score of National Research Corp is 6.14, ranking 110/156 in the Professional & Commercial Services industry. Its current P/E ratio is 26.42, which is 50.10% below the recent high of 39.66 and 62.81% above the recent low of 9.83.

Score

Industry at a Glance

Previous score
6.14
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 100/156
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2025-12-22

No earnings forecast score is currently available for National Research Corp. The Professional & Commercial Services industry's average is 7.70.

Score

Industry at a Glance

Previous score
0.00
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.
No Data

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-12-22

The current price momentum score of National Research Corp is 8.48, ranking 72/156 in the Professional & Commercial Services industry. Currently, the stock price is trading between the resistance level at 20.39 and the support level at 16.37, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
9.04
Change
-0.56

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(1)
Neutral(2)
Buy(2)
Indicators
Value
Direction
MACD(12,26,9)
0.217
Buy
RSI(14)
69.979
Neutral
STOCH(KDJ)(9,3,3)
87.066
Overbought
ATR(14)
0.775
High Vlolatility
CCI(14)
88.310
Neutral
Williams %R
9.340
Overbought
TRIX(12,20)
0.811
Sell
StochRSI(14)
22.593
Buy
Moving Average
Sell(0)
Neutral(0)
Buy(6)
Indicators
Value
Direction
MA5
18.906
Buy
MA10
18.295
Buy
MA20
17.423
Buy
MA50
15.285
Buy
MA100
14.889
Buy
MA200
14.433
Buy

Institutional Confidence

Currency: USD Updated: 2025-12-22

The current institutional shareholding score of National Research Corp is 5.00, ranking 99/156 in the Professional & Commercial Services industry. The latest institutional shareholding proportion is 51.61%, representing a quarter-over-quarter decrease of 47.07%. The largest institutional shareholder is The Vanguard, holding a total of 921.40K shares, representing 4.07% of shares outstanding, with 0.68% decrease in holdings.

Score

Industry at a Glance

Previous score
5.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
Amandla MK Trust
4.76M
--
Common Property Trust LLC
3.85M
--
Kayne Anderson Rudnick Investment Management, LLC
2.99M
-1.25%
Hays (Michael D)
1.39M
+1326.95%
The Vanguard Group, Inc.
Star Investors
919.55K
-1.44%
BlackRock Institutional Trust Company, N.A.
862.15K
-8.71%
Atlanta Capital Management Company, L.L.C.
704.75K
-6.46%
Dimensional Fund Advisors, L.P.
531.20K
-4.17%
Green (Trent S.)
500.00K
--
Geode Capital Management, L.L.C.
404.30K
-9.47%
1
2

Risk Assessment

Currency: USD Updated: 2025-12-22

The current risk assessment score of National Research Corp is 4.52, ranking 99/156 in the Professional & Commercial Services industry. The company's beta value is 0.47. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.

Score

Industry at a Glance

Previous score
4.52
Change
0
Beta vs S&P 500 index
0.47
VaR
+3.78%
240-Day Maximum Drawdown
+45.92%
240-Day Volatility
+55.48%

Return

Best Daily Return
60 days
+16.02%
120 days
+16.02%
5 years
+16.02%
Worst Daily Return
60 days
-4.16%
120 days
-7.70%
5 years
-16.47%
Sharpe Ratio
60 days
+2.80
120 days
+0.76
5 years
-0.31

Risk Assessment

Maximum Drawdown
240 days
+45.92%
3 years
+78.35%
5 years
+81.00%
Return-to-Drawdown Ratio
240 days
+0.19
3 years
-0.24
5 years
-0.15
Skewness
240 days
+0.23
3 years
-0.21
5 years
-0.34

Volatility

Realised Volatility
240 days
+55.48%
5 years
+40.12%
Standardised True Range
240 days
+3.80%
5 years
+5.69%
Downside Risk-Adjusted Return
120 days
+141.09%
240 days
+141.09%
Maximum Daily Upside Volatility
60 days
+51.29%
Maximum Daily Downside Volatility
60 days
+23.20%

Liquidity

Average Turnover Rate
60 days
+0.44%
120 days
+0.42%
5 years
--
Turnover Deviation
20 days
+27.05%
60 days
+21.28%
120 days
+15.40%

Peer Comparison

Professional & Commercial Services
National Research Corp
National Research Corp
NRC
5.49 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Maximus Inc
Maximus Inc
MMS
8.81 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
McGrath RentCorp
McGrath RentCorp
MGRC
8.70 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
S&P Global Inc
S&P Global Inc
SPGI
8.69 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Brady Corp
Brady Corp
BRC
8.66 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Ennis Inc
Ennis Inc
EBF
8.57 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more

FAQs

How does TradingKey generate the Stock Score of National Research Corp?

The TradingKey Stock Score provides a comprehensive assessment of National Research Corp based on 34 indicators derived from over 100 underlying data points.
These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of National Research Corp’s performance and outlook.

How do we generate the financial health score of National Research Corp?

To generate the financial health score of National Research Corp, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns.
By integrating these comprehensive data, the financial health score not only reflects National Research Corp's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of National Research Corp.

How do we generate the company valuation score of National Research Corp?

To generate the company valuation score of National Research Corp, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare National Research Corp’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value.
By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of National Research Corp’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of National Research Corp.

How do we generate the earnings forecast score of National Research Corp?

To calculate the earnings forecast score of National Research Corp, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:
Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.
Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.
By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.
Comparing these indicators against peers provides context for the stock’s performance and helps anchor more realistic expectations.
These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on National Research Corp’s future.

How do we generate the price momentum score of National Research Corp?

When generating the price momentum score for National Research Corp, we examine momentum indicators including support and resistance levels as well as volume metrics.
Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.
This comprehensive approach can reflect market sentiment and enable rational forecasts of National Research Corp’s prices. A higher score indicates a more stable short-term price trend for National Research Corp.

How do we generate the institutional confidence score of National Research Corp?

To generate the institutional confidence score of National Research Corp, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about National Research Corp’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of National Research Corp.

How do we generate the risk management score of National Research Corp?

To assess the risk management score of National Research Corp, we examine multiple key indicators related to returns, risk, volatility, and liquidity.
The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.
These indicators together provide a multi-dimensional understanding of National Research Corp’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of National Research Corp.
KeyAI